During the omicron wave, the Pfizer or Moderna COVID-19 vaccine was 87% effective at preventing emergency and urgent care visits and 95% effective at preventing hospitalizations in adults who received a third dose in the prior two months, according to a study released Friday by the Centers for Disease Control and Prevention. A third dose was more effective than a second dose but less effective over time, the study found. 

In a separate study reported Friday, adverse reactions were less frequent after a third dose than a second dose in adults who received the same COVID-19 vaccine for all their doses. 
 

Related News Articles

Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…